A phase 3 study of induction treatment with concurrent chemoradiotherapy versus chemotherapy before surgery in patients with pathologically confirmed N2 stage IIIA nonsmall cell lung cancer (WJTOG9903).

MLA

Katakami, Nobuyuki, et al. “A Phase 3 Study of Induction Treatment with Concurrent Chemoradiotherapy versus Chemotherapy before Surgery in Patients with Pathologically Confirmed N2 Stage IIIA Nonsmall Cell Lung Cancer (WJTOG9903).” Cancer, vol. 118, no. 24, Dec. 2012, pp. 6126–35. EBSCOhost, https://doi.org/10.1002/cncr.26689.

APA

Katakami, N., Tada, H., Mitsudomi, T., Kudoh, S., Senba, H., Matsui, K., Saka, H., Kurata, T., Nishimura, Y., & Fukuoka, M. (2012). A phase 3 study of induction treatment with concurrent chemoradiotherapy versus chemotherapy before surgery in patients with pathologically confirmed N2 stage IIIA nonsmall cell lung cancer (WJTOG9903). Cancer, 118(24), 6126–6135. https://doi.org/10.1002/cncr.26689

Chicago

Katakami, Nobuyuki, Hirohito Tada, Tetsuya Mitsudomi, Shinzoh Kudoh, Hiroshi Senba, Kaoru Matsui, Hideo Saka, Takayasu Kurata, Yasumasa Nishimura, and Masahiro Fukuoka. 2012. “A Phase 3 Study of Induction Treatment with Concurrent Chemoradiotherapy versus Chemotherapy before Surgery in Patients with Pathologically Confirmed N2 Stage IIIA Nonsmall Cell Lung Cancer (WJTOG9903).” Cancer 118 (24): 6126–35. doi:10.1002/cncr.26689.